» Articles » PMID: 11116058

Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-specific Expression of Scavenger Receptor-A

Overview
Date 2000 Dec 16
PMID 11116058
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The absence of the scavenger receptor A (SR-A)-I/II has produced variable effects on atherosclerosis in different murine models. Therefore, we examined whether SR-AI/II deficiency affected atherogenesis in C57BL/6 mice, an inbred strain known to be susceptible to diet-induced atherosclerotic lesion formation, and whether the deletion of macrophage SR-AI/II expression would modulate lesion growth in C57BL/6 mice and LDL receptor (LDLR)(-/-) mice. SR-AI/II-deficient (SR-AI/II(-/-)) female and male mice on the C57BL/6 background were challenged with a butterfat diet for 30 weeks. No differences were detected in plasma lipids between SR-AI/II(-/-) and SR-AI/II(+/+) mice, whereas both female and male SR-AI/II(-/-) mice had a tremendous reduction (81% to 86%) in lesion area of the proximal aorta compared with SR-AI/II(+/+) mice. Next, to analyze the effect of macrophage-specific SR-AI/II deficiency in atherogenesis, female C57BL/6 mice were lethally irradiated, transplanted with SR-AI/II(-/-) or SR-AI/II(+/+) fetal liver cells, and challenged with the butterfat diet for 16 weeks. In a separate experiment, male LDLR(-/-) mice were reconstituted with SR-AI/II(-/-) or SR-AI/II(+/+) fetal liver cells and challenged with a Western diet for 10 weeks. No significant differences in plasma lipids and lipoprotein profiles were noted between the control and experimental groups in either experiment. SR-AI/II(-/-)-->C57BL/6 mice, however, had a 60% reduction in lesion area of the proximal aorta compared with SR-AI/II(+/+)-->C57BL/6 mice. A similar level of reduction (60%) in lesion area was noted in the proximal aorta and the entire aorta en face of SR-AI/II(-/-)-->LDLR(-/-) mice compared with SR-AI/II(+/+)-->LDLR(-/-) mice. These results demonstrate in vivo that SR-AI/II expression has no impact on plasma lipid levels and that macrophage SR-AI/II contributes significantly to atherosclerotic lesion formation.

Citing Articles

Blue Mussel-Derived Bioactive Peptides PIISVYWK (P1) and FSVVPSPK (P2): Promising Agents for Inhibiting Foam Cell Formation and Inflammation in Cardiovascular Diseases.

Marasinghe C, Je J Mar Drugs. 2024; 22(10).

PMID: 39452874 PMC: 11509633. DOI: 10.3390/md22100466.


Innate Immune Pathways in Atherosclerosis-From Signaling to Long-Term Epigenetic Reprogramming.

Aronova A, Tosato F, Naser N, Asare Y Cells. 2023; 12(19).

PMID: 37830572 PMC: 10571887. DOI: 10.3390/cells12192359.


Monocyte and macrophage foam cells in diabetes-accelerated atherosclerosis.

Cervantes J, Kanter J Front Cardiovasc Med. 2023; 10:1213177.

PMID: 37378396 PMC: 10291141. DOI: 10.3389/fcvm.2023.1213177.


LDL delivery of microbial small RNAs drives atherosclerosis through macrophage TLR8.

Allen R, Michell D, Cavnar A, Zhu W, Makhijani N, Contreras D Nat Cell Biol. 2022; 24(12):1701-1713.

PMID: 36474072 PMC: 10609361. DOI: 10.1038/s41556-022-01030-7.


The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer.

Gudgeon J, Marin-Rubio J, Trost M Front Immunol. 2022; 13:1012002.

PMID: 36325338 PMC: 9618966. DOI: 10.3389/fimmu.2022.1012002.